Case number 1:18-cv-00117
Teva Pharmaceuticals International GmbH et al v. Slayback Pharma Limited Liability Company > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 6, 2020 | N/A | Terminated Case (0) Docket Text: CASE CLOSED per Final Judgment Order in Lead Case. CA. NO. 17-1154-CFC. (fms) |
| Sep 25, 2018 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Reassigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:17-cv-01154-CFC, 1:17-cv-01164-CFC, 1:17-cv-01201-CFC, 1:17-cv-01790-CFC, 1:18-cv-00117-CFC (rjb) |
| Jul 25, 2018 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Reassigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. Associated Cases: 1:17-cv-01154-LPS, 1:17-cv-01164-LPS, 1:17-cv-01201-LPS, 1:17-cv-01790-LPS, 1:18-cv-00117-LPS (rjb) |
| Mar 20, 2018 | N/A | Remark (0) Docket Text: Remark - This case has been consolidated for all purposes with Lead C.A. No. 17-1154-GMS. All future filings shall be made ONLY in the Lead Case. (mdb) |
| Mar 19, 2018 | 14 | SO ORDERED (3) Docket Text: SO ORDERED, re [12] Stipulation for Consolidation and to Extend Case Deadlines filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH, Eagle Pharmaceuticals, Inc. Signed by Judge Gregory M. Sleet on 3/19/2018. (asw) |
| Mar 16, 2018 | 13 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Initial Identification of Asserted Patents and Accused Products filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH.(Hoeschen, Nathan) |
| Mar 14, 2018 | 12 | Stipulation (3) Docket Text: STIPULATION (and proposed order) for Consolidation and to Extend Case Deadlines by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Feb 12, 2018 | 9 | Answer to Complaint (26) Docket Text: ANSWER to [1] Complaint, Additional Defenses, COUNTERCLAIM against All Plaintiffs by Slayback Pharma Limited Liability Company.(Ormerod, Eve) Modified on 2/12/2018 (mdb). |
| Feb 12, 2018 | 10 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate KKR & Co. for Slayback Pharma Limited Liability Company filed by Slayback Pharma Limited Liability Company. (Belgam, Neal) |
| Feb 12, 2018 | 11 | Order (2) Docket Text: ORDER REGARDING CASE MANAGEMENT IN CIVIL CASES. Signed by Judge Gregory M. Sleet on 2/12/2018. (asw) |
| Jan 24, 2018 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Gregory M. Sleet. Please include the initials of the Judge (GMS) after the case number on all documents filed. (rjb) |
| Jan 22, 2018 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Slayback Pharma Limited Liability Company on 1/22/2018. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (fms) |
| Jan 22, 2018 | 8 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Teva Pharmaceuticals International GmbH, Cephalon, Inc., Eagle Pharmaceuticals, Inc.. Slayback Pharma Limited Liability Company served on 1/22/2018, answer due 2/12/2018. (Keller, Karen) |
| Jan 19, 2018 | 1 | Exhibit A (29) |
| Jan 19, 2018 | 1 | Exhibit B (18) |
| Jan 19, 2018 | 1 | Civil Cover Sheet (1) |
| Jan 19, 2018 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (fms) |
| Jan 19, 2018 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 12/8/2017. Date of Expiration of Patent: 3/15/2033.Thirty Month Stay Deadline: 6/8/2020. (fms) |
| Jan 19, 2018 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 9,572,887 B2. (fms) |
| Jan 19, 2018 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Teva Pharmaceutical Industries Ltd., Other Affiliate Teva Ltd. for Teva Pharmaceuticals International GmbH filed by Teva Pharmaceuticals International GmbH. (fms) |
| Jan 19, 2018 | 6 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Teva Pharmaceutical Industries Ltd., Other Affiliate Teva Ltd. for Cephalon, Inc. filed by Cephalon, Inc. (fms) |
| Jan 19, 2018 | 7 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Janus Henderson Group PLC for Eagle Pharmaceuticals, Inc. filed by Eagle Pharmaceuticals, Inc. (fms) |
| Jan 19, 2018 | 1 | Complaint* (1) |
